# Hub Support

I have an investment memo that is almost ready for IC, but I still need to add one thing. I mistakenly hit "pass" on it (since it was not ready). The deal is now is marked as declined. And now I don't know how to reverse that. Is there a function or feature that lets me put that back into the decision stage? Thanks so much!!

Dropdown in community deals:

1. Please order reasonably - I suggest alphabetically
2. Why does it get weird at bottom?

I want to submit a deal for IC review, I am not able to see the option on my decilehub.

I have several PACT commitments, but they aren't autopopulated.  What can I do to have them show up?

Automatic contract import

Is there a email importer similar to what has been set up for deal flow but for importing contacts? I use pipeline-{fund name}+deals@decilehubemail.com for deal import, for example.

We are currently preparing an LP event in the Philippines and noticed that Manila is not available as a timezone option when creating event invitations. While Singapore and Hong Kong are available and share the same UTC+8 timezone, we would prefer to display Manila (Philippine Time) to better reflect the event's location and audience.

Would it be possible to add Manila as a timezone option?

Thank you very much for your help. 

Speed is the feature. Which parts of your application take more then 3 seconds to load? I know a new newsletter takes 20+ seconds...

Good morning,
I logged onto hub this morning, and my pipelines are showing up as no prospects to show.  Please advise.
Thank you,
Eric

Hello, I would love to be able to customise font sizes within an event description on Decile Hub. In this case, to provide a disclaimer at the bottom of the event, but being able to write the description in html would be even better. Is this possible any time soon? Thank you!

I have issues sending out emails to prospectus due to integration errors. The system disconnects me as soon as I send out the email and states "my google out is disconnected". I have tried sending emails out in "incognito" mode and I get the same error. Thx

Hub doesn't let me save thesis. Just redirects to a blank page....

I have an LP prospect who wants to invest from an IRA. How do I need to set this up?

I mistakenly deleted a file from an investor's folder and would like to restore it. Is there a backup or any recovery option available that would allow me to retrieve the file?

When creating a new newsletter I love the copy a previous template feature, but I send a lot of emails so they old ones get buried and unselectable pretty fast. Would love to have a simple search here or maybe just load the last 25 emails instead of just 5 that it does currently?

I have tried updating the PACT agreement several times to remove the language in item 3 that refers to US securities law. When I click Preview this PACT, it reverts to the original language, and when I go back to the Pact Agreement, it reverts to the original language as well.  Any thoughts on what I can do?

Hello, Please note that I am not able to integrate my Google account with Decilehub. I go through the connection process and the system gets connected but immediately I am disconnected. I would appreciate your help in resolving this. Thx

does decile hub need "gmail sync"? or just gmail send?

The Start Fund Investment Lead Agreement says that I'm an Investment Lead, which is distinguished from a GP. I thought I was the GP of our Fund 1.

Can someone shed some light? Thank you.

I have a login issue with my account, 

how can I update current valuation of a portfolio company?

There is no way we know 163 people in the Netherlands and 79 in Ireland - how are the geo stats being calculated?

Is there a way to see all tasks across all workflows (i.e., fundraising, dealflow, connectors, recruiting, custom)? 

Can I create a form in Decile Hub that I can use to gather name, address, email, and phone number information from prospects and have this data create a person directly? The use case is that I want to send out an invitation to people to attend an event, familiarising them with the New Zealand Golden Visa. My fund is an eligible investment under this program, and I want the invite to include a link that allows them to enter the event information and add it to the Decile Person DB.

It looks like Merge Duplicates exposes SS#.  That is very confidential info and I think you need to consider how you keep this more hidden.

Does anyone have "fund advisors" helping them? Meaning they will help open their network for a percentage. Do we need to talk to legal about this? Do we have a legal team?

how to remove a pipeline?

Can we expose the "LP Commitments" (the total amount signed/wired by limited partners so far) to the API?

Hi, we I downloaded the skill, API key is hadrcoded, It was almost commited to a repo, this is a security concern for me

How can I change the title of someone in the Directory

How do I make a new email template in Decile Hub? 

Apparently there is no way to remove a tag from a prospect using API.

1. IF there is a way, please tell me how.
2. If not, please add this fix ASAP.

As part of Sprint 0 Set 3 we are asked to "Next, test your VC 101 knowledge with the quizzes and additional research available here (https://decilegroup.com/ai)" There are is no quiz at this link nor anywhere on the decile hub or decile group website. Has this been moved or removed? 

I can't find : Decile Hub fund settings

I am getting this message, but clicking on it doesn't take me to the checklist (just to the main dashboard). I'm trying to figure out what the missing step is to complete the task. 

How can I change the Primary Account 

Can you please explain why there is now a regular API key and a legacy API key? 
What is difference?  Why should I bother switching?

How can I create a custom form to collect prospect Name, Address, Email, and phone?

Events - Wrong Default Time Zone

I don't know if anyone else is getting this, but the default time zone when creating a new event is coming up as Mountain Time for me, and I'm in Central Time. 

AI Form Assistant did this...

Also, it overwrote correct info.  I don't think it shoudl be overwriting.

I get this message.

 A task for Calvin Yoon has been updated from "Automated" to "Manual" in the Investors pipeline. Hub attempted to run an automatic task for Calvin Yoon but it was unsuccessful and the automation has been paused. See details below  | Firm name: |  Reflect Ventures
| Pipeline: | Investors
| Stage: |  S.010 Cold Add
| Prospect: |  Calvin Yoon <No email>
| Email action: | https://reflectventures.decilehub.com/email_templates/3830716?pipeline_id=Lnp4lMvn
| Error(s): | This prospect does not have an email address
|  Developer notes:
[{"variable_name":"","error_type":"This prospect does not have an email address","variable_type":null,"variable_id":null}] 
|

How do I add  private@decilegroup.com  to my newsletter?

When I try to send an email using a template from the People Directory it deletes the email address and does not sub in the variables.

When I send out newsletters a small number of them seem to automatically and immediately show that the recipient clicked on some links.

I do not believe that all of these people opened, read, and clicked on link in same minute. 

@Woody Butler Why does my decilepro.com page show this spew on the right side of my page in preview mode?  "The Pharmacy Innovator Fund is a $5M seed-stage fund investing in technology companies modernizing U.S. pharmacy infrastructure. Our focus spans both B2B and B2C solutions that improve pharmacy economics and enable pharmacists to expand their clinical service offerings at scale. FUND SHEET - PHARMACY INNOVATOR FUND FUND OVERVIEW Fund Name: Pharmacy Innovator Fund Fund Structure: Start Fund (Series of Decile Start Fund, LP) Fund Size: $5,000,000 Investment Stage: Seed (Pre-seed to Seed) Target Sectors: Pharmacy technology, healthcare infrastructure, B2B/B2C software Geography: United States Fund Life: 10 years (+ 2 one-year extensions) Vintage Year: 2025 Close Minimum: $100,000 ECONOMICS Management Fee Structure: 1% annually (Start Fund model) - Year 1: 5% of fund size ($250,000) - Year 2: 5% of fund size ($250,000) - Years 3-10: 0% - Total Management Fees: $500,000 (10% of fund) Carried Interest: 18% (to Decile Group as fund sponsor) Preferred Return (Hurdle): 8% annually to LPs Fund Expenses: $0 (all operational costs covered by Decile Group) Investible Capital: $4,500,000 (90% of fund size) INVESTMENT STRATEGY Target Number of Investments: 20 companies Average Investment Size: $225,000 Target Ownership Range: 3-5% per company Reserve Ratio: 30% for follow-on investments Initial Investment Capital: $3,150,000 (70% of investible capital) Follow-on Reserve Capital: $1,350,000 (30% of investible capital) PORTFOLIO CONSTRUCTION Stage Focus: Pre-seed to Seed Target Entry Valuation Range: $3M - $8M post-money Check Size Range: $150K - $350K initial investment Expected Dilution at Exit: 50-70% from initial ownership Target Hold Period: 5-8 years Investment Pace: 8-10 companies Year 1, 6-8 companies Year 2, 4-6 companies Year 3 ALLOCATION TABLE | Metric | Value | | Number of Portfolio Companies | 20 | | Average Investment Amount | $225,000 | | Target Entry Valuation | $5,500,000 | | Target Ownership at Investment | 4.1% | RETURN PROJECTIONS - CONSERVATIVE CASE Failure Rate: 70% (14 companies return $0) Exit Distribution: - Failures: 14 companies @ $0 = $0 - Low Exits: 4 companies @ $8M exit value = $738,000 (4.1% initial ownership × 50% dilution = 2.05% at exit) - Medium Exits: 1 company @ $25M exit value = $256,250 (4.1% initial ownership × 60% dilution = 1.64% at exit) - High Exits: 1 company @ $75M exit value = $922,500 (4.1% initial ownership × 70% dilution = 1.23% at exit) Total Portfolio Returns: $1,916,750 Less Preferred Return (8% × $5M × 7 years avg): $2,800,000 Preferred Return Shortfall: ($883,250) Carried Interest: $0 (no carry until preferred return met) Net LP Returns: $1,916,750 TVPI: 0.38x IRR: -11% RETURN PROJECTIONS - BASE CASE Failure Rate: 60% (12 companies return $0) Exit Distribution: - Failures: 12 companies @ $0 = $0 - Low Exits: 5 companies @ $10M exit value = $1,025,000 (4.1% initial ownership × 50% dilution = 2.05% at exit) - Medium Exits: 2 companies @ $30M exit value = $984,000 (4.1% initial ownership × 60% dilution = 1.64% at exit) - High Exits: 1 company @ $100M exit value = $1,230,000 (4.1% initial ownership × 70% dilution = 1.23% at exit) Total Portfolio Returns: $3,239,000 Less Preferred Return (8% × $5M × 7 years avg): $2,800,000 Profit Above Preferred: $439,000 Carried Interest (18%): $79,020 Net LP Returns: $3,159,980 TVPI: 0.63x IRR: -6% RETURN PROJECTIONS - UPSIDE CASE Failure Rate: 50% (10 companies return $0) Exit Distribution: - Failures: 10 companies @ $0 = $0 - Low Exits: 6 companies @ $15M exit value = $1,845,000 (4.1% initial ownership × 50% dilution = 2.05% at exit) - Medium Exits: 3 companies @ $50M exit value = $2,460,000 (4.1% initial ownership × 60% dilution = 1.64% at exit) - High Exits: 1 company @ $150M exit value = $1,845,000 (4.1% initial ownership × 70% dilution = 1.23% at exit) Total Portfolio Returns: $6,150,000 Less Preferred Return (8% × $5M × 7 years avg): $2,800,000 Profit Above Preferred: $3,350,000 Carried Interest (18%): $603,000 Net LP Returns: $5,547,000 TVPI: 1.11x IRR: 1.5% RETURN PROJECTIONS - OPTIMISTIC CASE Failure Rate: 40% (8 companies return $0) Exit Distribution: - Failures: 8 companies @ $0 = $0 - Low Exits: 7 companies @ $20M exit value = $2,870,000 (4.1% initial ownership × 50% dilution = 2.05% at exit) - Medium Exits: 3 companies @ $75M exit value = $3,690,000 (4.1% initial ownership × 60% dilution = 1.64% at exit) - High Exits: 2 companies @ $200M exit value = $4,920,000 (4.1% initial ownership × 70% dilution = 1.23% at exit) Total Portfolio Returns: $11,480,000 Less Preferred Return (8% × $5M × 7 years avg): $2,800,000 Profit Above Preferred: $8,680,000 Carried Interest (18%): $1,562,400 Net LP Returns: $9,917,600 TVPI: 1.98x IRR: 10.5% FUND-RETURNING SCENARIO (3.0x TVPI TARGET) To achieve 3.0x TVPI ($15M total returns to LPs): Required Gross Portfolio Returns: $18,300,000 Realistic Path: - 2 companies exit at $250M+ with 1.2% ownership = $6,000,000 - 3 companies exit at $75-100M with 1.6% ownership = $4,200,000 - 5 companies exit at $25-50M with 2.0% ownership = $6,500,000 - 10 companies fail or return minimal capital = $1,600,000 Total: $18,300,000 gross returns COMPETITIVE ADVANTAGES 1. Market Foresight: 18-24 month advance visibility through NCPDP, NABP, NCPA board positions providing early insight into regulatory changes and payment pathway developments 2. Proprietary Deal Flow: Direct access to pharmacy ecosystem founders through governance roles and standards organizations 3. Value-Add Capabilities: Regulatory guidance, standards adoption support, and deployment assistance in community, rural, and underserved practice settings 4. Network Effects: Deep connections across independent pharmacies, chains, and pharmacy organizations for customer introductions and pilot programs 5. Timing Advantage: Policy enablement (CMS ACCESS, LEAD models) creating immediate infrastructure demand INVESTMENT CRITERIA Must-Haves: - Addresses pharmacy workflow, payment infrastructure, data interoperability, compliance, or care delivery enablement - Founder with pharmacy/healthcare domain expertise or deep understanding of pharmacy operations - Clear path to revenue within 12 months of investment - Defensible technology, network effects, or regulatory moat - Strong alignment with regulatory trends and reimbursement pathway evolution Nice-to-Haves: - Existing pharmacy customer traction or pilot programs - Standards-based approach (NCPDP, HL7, FHIR compliance) - Native integration capabilities with existing pharmacy management systems - Pharmacist founder or co-founder on the team - Participation from strategic pharmacy industry angels DEPLOYMENT TIMELINE Year 1 (2025): $1,800,000 deployed (8-10 initial investments) Year 2 (2026): $1,350,000 deployed (6-8 initial investments) Year 3 (2027): $900,000 deployed (4-6 initial investments + follow-ons) Years 4-5 (2028-2029): $450,000 reserved (follow-on investments in top performers) EXIT TIMELINE Years 1-5 (2025-2029): Active investment period Years 6-8 (2030-2032): Early exits begin (strategic acquisitions, secondary sales) Years 9-12 (2033-2036): Major exits expected (larger acquisitions, potential IPOs) FUND PERFORMANCE METRICS Target Metrics: - TVPI: 3.0x+ (top quartile) - DPI: 2.5x+ (cash returned to LPs) - IRR: 25%+ (top quartile) - Loss Ratio: <50% (better than industry average) Benchmark Comparison: - Top Quartile Seed Funds: 3.5x+ TVPI, 30%+ IRR - Median Seed Funds: 1.8x TVPI, 15% IRR - Healthcare Seed Funds: 2.2x TVPI, 18% IRR - Pharmacy Innovator Fund Target: 3.0x TVPI, 25% IRR RISK FACTORS 1. Regulatory Risk: Changes to pharmacy scope of practice, reimbursement models, or federal healthcare policy could impact portfolio company viability 2. Market Consolidation Risk: Continued consolidation of independent pharmacies could reduce addressable market for B2B solutions 3. Technology Integration Risk: Legacy pharmacy systems and resistance to change could slow adoption of new infrastructure 4. Competition Risk: Large healthcare IT vendors (Epic, Cerner, Surescripts) entering pharmacy infrastructure space 5. Execution Risk: First-time fund manager without prior institutional fund track record MITIGATION STRATEGIES 1. Portfolio Diversification: 20 companies across multiple pharmacy infrastructure subsectors reduces single-point failure risk 2. Infrastructure Focus: Targeting enabling infrastructure vs. consumer-facing solutions provides more defensible positioning 3. Regulatory Expertise: Deep involvement in standards organizations and policy development provides advance warning and adaptation capability 4. Founder Selection: Rigorous screening for domain expertise, execution capability, and market timing 5. Conservative Modeling: Base case assumes 60% failure rate and modest exit multiples, with upside scenarios requiring achievable outcomes LP REPORTING SCHEDULE Quarterly Reports: Portfolio updates, NAV calculations, capital call notices, distribution notices Annual Reports: Audited financial statements, K-1 tax documents, comprehensive performance review Ad Hoc Communications: Material events, new investments, exits, significant portfolio developments FUND ADMINISTRATION Administrator: Decile Group (full-service fund administration) Legal Counsel: Provided through Decile Start Fund structure Accounting: Provided through Decile Start Fund structure Compliance: Provided through Decile Start Fund structure Banking: Established through Decile Start Fund structure CONTACT INFORMATION Christian Tadrus, PharmD Investment Lead, Pharmacy Innovator Fund Tadrus Advisory Group, LLC Email: christian@tadrusadvisory.group Phone: 660.998.0291 Fund Website: https://decilepro.com/access/tag This Fund Sheet was prepared for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any securities. The Pharmacy Innovator Fund is offered only to qualified investors pursuant to applicable exemptions from registration under federal and state securities laws.

"

File sharing is not working, where do I need to add a person to view and download a file?

Quick question, how do I integrate my email with the decile mail tool

 I cannot find the left navigation panel of my Decile Hub. Can you please enable the newsletter? Thanks in advance.

Best regards,
Malik

how do I add a user to Decile Hub?

Something seems to have gone wrong with the extension.  I am trying to import this person, but most of the fields for import are missing.

https://www.linkedin.com/in/james-graham-04326b2/

There is no pipeline or stage, name of person, location, etc.

How do I filter a pipeline by State?

I need to find all LPs in California so I can identify all that are in or near Los Angeles.  So can't just filter by city.

It makes no sense that we can filter by country or city but not state.